A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify research related to the generation of T cells, both alpha... read more →
BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. BioMarin Pharmaceutical Inc. is looking for expertise in the pathology and... read more →
BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. C‐type natriuretic peptide (CNP) is a growth factor with receptors expressed... read more →